Skip to main content
Equibles
CTRE logo

CTRE · CareTrust REIT, Inc.

Track CTRE — free

Use CTRE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CTRE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$36.40 +0.56 (+1.55%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$8.47B
Shares
236.29M
Volume · Oct 20 834.07K Avg daily vol (3M) 2.31M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$35.84 Open$36.36 Day$35.82–36.63 52W close$33.99–43.40 Avg vol 30d2.5M Short int11.0M · 4.6% float · 4.7d Short vol46% Last earningsAug 7, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 2 wks
Latest filing: 10-Q
filed Aug 6, 2026
Q2 2026 earnings call transcript
call held Aug 7, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$571.43M
Trailing 12 months
Net income (TTM)
$355.40M
Trailing 12 months
Revenue growth YoY
+43.5%
Year over year
Operating margin
—
Trailing 12 months
P / FFO
22.8×
Company-stated · TTM · reciprocal yield 4.4%
P / E (TTM)
22.3
Trailing earnings · reciprocal yield 4.5%
Return on invested capital
—
Trailing 12 months
Net cash
−$1.16B
Latest balance sheet
Dividend yield
4.2%
Trailing 12 months
Shares change YoY
+21.5%
Year over year · more shares
Price change (1Y)
+3.6%
Trailing year
Short interest
4.6%
Latest settlement · 4.7 days to cover
View all 126 metrics

Quarterly results

Revenue Net income Net loss
▲38.5% $77.38M $33.44M '24 Q3 ▲45.6% $86.94M $52.13M '24 Q4* ▲53.2% $96.62M $65.80M '25 Q1 ▲63.3% $112.47M $68.55M '25 Q2 ▲71.2% $132.44M $74.90M '25 Q3 ▲55.1% $134.86M $111.29M '25 Q4* ▲47.8% $142.78M $80.21M '26 Q1 LATEST ▲43.5% $161.35M $89.00M '26 Q2

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very Low
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −8%
below
Price vs 50-day avg −6%
below
RSI (14) 36
neutral
MACD trend Positive
52-week position 20%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −5%
trailing
6-month return −10%
trailing
YTD return −1%
this year
Relative strength −17%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $38 › 200d $39 — 200d above 50d
Institutional flow Distributing
56 of 519 funds reported for Sep 30 · net -535.6K sh shares · +8 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.64% of float · ▼ -32.5% MoM · 4.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
519 holders — near 3-yr high, broad support
Squeeze score 60
elevated · 0–100
Fundamentals
Excellent
Revenue growth +61%
Y/Y
EPS growth +96%
Y/Y
Free cash flow $391.1M
Valuation P/E 22.3
below peers
Buyback $150.0M
remaining
Balance sheet $696.2M
net debt
Quant / Vol
risk profile
Very Low
Volatility 25%
annualized · 1-yr
Max drawdown −18%
past year
ATR 2.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 7, 2026
Normalized FFO per share · full year 2026 Non-GAAP Raised $2.03 – $2.06
May 8, 2026 $2.00 – $2.04 changed to Aug 7, 2026 $2.03 – $2.06
Normalized FAD per share · full year 2026 Non-GAAP Raised $2.01 – $2.04
May 8, 2026 $1.98 – $2.02 changed to Aug 7, 2026 $2.01 – $2.04
Prior guidance period ended · from the Earnings Call filed Nov 6, 2025
Normalized FFO per share · full year 2025 $176.00 – $177.00
Normalized FAD per share · full year 2025 $176.00 – $177.00
Straight-line rent · full year 2025 $9M
Interest income from financing receivables · full year 2025 $12M
Interest income · full year 2025 $96M
Interest expense · full year 2025 $44M
G&A expense · full year 2025 $52M – $53M
Income tax expense · full year 2025 $5M
Guided vs delivered · last 1 settled
Net income Full Year 2025
guided $1.41 – $1.42
$1.57 Beat +11.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−8% Bearish
Price vs 50-day avg
−6% Bearish
RSI (14)
36 Neutral
MACD trend
Positive Bullish
52-week position
20% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $38 › 200d $39 — 200d above 50d
Institutional flow Distributing
56 of 519 funds reported for Sep 30 · net -535.6K sh shares · +8 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.64% of float · ▼ -32.5% MoM · 4.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
519 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $34 Now $36 · 20% Range high $43
vs 200-day avg -8% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Annualized Normalized Run Rate EBITDA attributable to CareTrust REIT, Inc. non-GAAP $579.31M Q2 2026 —
Blended stabilized yield on Q2 investment activity 8.9% Q2 2026 —
Consolidated Leverage Ratio 16% Q2'26 —
Contractual rent and interest collection 100% Q2 2026 —
EBITDA attributable to CareTrust REIT, Inc. 137.4M Three Months Ended June 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net income attributable to CareTrust REIT, Inc. 89M
+30.36M Depreciation and amortization
-2.84M Noncontrolling interests' share of real estate related depreciation and amortization
+15.32M Interest expense
+2.54M Income tax expense
+3.02M Amortization of stock-based compensation
+0K Amortization of stock-based compensation related to extraordinary incentive plan
= EBITDA attributable to CareTrust REIT, Inc. 137.4M
FAD attributable to CareTrust REIT, Inc. non-GAAP 222.26M Six Months Ended June 30, 2026 —
FAD per share attributable to CareTrust REIT, Inc. non-GAAP $0.49 Three Months Ended June 30, 2026 —
FFO attributable to CareTrust REIT, Inc. non-GAAP 223.05M Six Months Ended June 30, 2026 —
FFO per share attributable to CareTrust REIT, Inc. non-GAAP $0.5 Three Months Ended June 30, 2026 —
Gross asset value $6.55B Q2'26 —
Investment activity $899.6M Q2 2026 —
Normalized EBITDA attributable to CareTrust REIT, Inc. non-GAAP 264.98M Six Months Ended June 30, 2026 —
Normalized FAD non-GAAP $118.5M Q2 2026 —
Normalized FAD attributable to CareTrust REIT, Inc. non-GAAP 226.06M Six Months Ended June 30, 2026 —
Normalized FAD per share attributable to CareTrust REIT, Inc. non-GAAP $0.51 Three Months Ended June 30, 2026 —
Normalized FFO non-GAAP $119.7M Q2 2026 —
Normalized FFO attributable to CareTrust REIT, Inc. non-GAAP 227.11M Six Months Ended June 30, 2026 —
Normalized FFO per share attributable to CareTrust REIT, Inc. non-GAAP $0.51 Three Months Ended June 30, 2026 —
Normalized Run Rate EBITDA attributable to CareTrust REIT, Inc. non-GAAP $144.83M Q2 2026 —
GAAP → non-GAAP reconciliation
GAAP Normalized EBITDA attributable to CareTrust REIT, Inc. 140.69M
+4.14M Full impact of quarterly investments
= Normalized Run Rate EBITDA attributable to CareTrust REIT, Inc. 144.83M
Total leverage ratio 18% Q2'26 —
Unencumbered gross assets $6.55B Q2'26 —
Unsecured leverage ratio 18% Q2'26 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CTRE
CareTrust REIT, Inc.
this stock
$8.47B -0.9% +60.8% 22.3 4.6%
WELL
Welltower Inc.
 $168.32B +25.8% +35.6% 109.9 2.5%
VTR
Ventas, Inc.
 $44.28B +9.2% +18.5% 159.9 3.2%
OHI
Omega Healthcare Investors Inc
 $13.60B +1.2% +13.2% 16.0 5.2%
DOC
Healthpeak Properties, Inc.
 $12.69B +14.4% +4.5% 52.6 3.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
520
% held
105.9%
Reported
56 of 519
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
523
View
Short & Settlement
Short Interest Falling
Shares short
11.0M
Days to cover
4.7d
Change
-5.3M sh
View
Short Volume
Short vol %
46%
As of
Oct 19, 2026
Short Total
View
Fails to Deliver
FTD shares
8.0K
Value
$299.3K
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
35.5%
Week of
Sep 14, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Daniel Goldman
Amount
$1.0K–$15.0K
Traded
Jul 12, 2023
View
Financials
Financials
Revenue (FY)
$476.4M
Net income (FY)
$320.5M
EPS diluted
$1.57
View
Buybacks
Authorized
$150.0M
Remaining
$150.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 2, 2026
This year
13
View
Proposed Sales
Value
$1.0M
Shares
35.0K
Filed
Sep 4, 2024
View
Earnings & Events
Webcasts
Last webcast
Aug 7, 2026
View
Investor Relations
Latest news
CareTrust Publishes Sixth Annual…
Published
Oct 9, 2026
View

Performance

5D 20D 120D MTD YTD
CTRE -2.2% -4.9% -9.8% -2.0% -0.9%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY -0.7% -4.0% -17.5% -2.5% -13.3%

Capital returns

Latest dividend
$0.39 / share · ex Sep 30, 2026
Raised 16.4%
Paid (TTM)
$1.505 / share · 4 payouts
Dividend yield (TTM, derived)
4.20%
Buyback program · as of Sep 30, 2022
Authorized
$150.00M
Spent (derived)
$0
Remaining
$150.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1590717 CUSIP 14174T107 13F (30d) 52 filings 52 filers Visit website Investor relations